{"id":160,"date":"2025-06-29T10:29:20","date_gmt":"2025-06-29T03:29:20","guid":{"rendered":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/"},"modified":"2025-06-29T10:29:20","modified_gmt":"2025-06-29T03:29:20","slug":"priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis","status":"publish","type":"post","link":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/","title":{"rendered":"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis"},"content":{"rendered":"<div>\n<div class=\"\">\n<div style=\"width:30%;float:left;max-width:525px;margin:0 1.5rem 1.5rem 0;clear:both;cursor:\" class=\" figure\">\n<div id=\"image-caption\" class=\"text-gray-500 italic\">\n<div class=\"blockText_blockContent__TbCXh\">\n<p class=\"pb-2\">Rendering 3D CAR &#8211; Reseptor antigen chimeric antara sel -T dan sel kanker | Kredit Gambar: \u00a9 Alpha Tauri 3D &#8211; Stock.adobe.com<\/p>\n<\/div>\n<\/div>\n<div class=\"hidden top-(-100%) block w-(1px) transition-opacity duration-500 ease-in-out opacity-0 overflow-hidden\"><img decoding=\"async\" class=\"m-auto absolute inset-0 max-w-(0%) max-h-(0%) border-(3px) border-solid border-white shadow-(0px_0px_8px_rgba(0,0,0,0.3)) box-border transition ease-in-out duration-500\" src=\"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500.jpg?fit=crop&amp;auto=format\"\/><\/div>\n<\/div>\n<\/div>\n<p class=\"pb-2\">Priothera, sebuah perusahaan biofarmasi tahap akhir yang berkantor pusat di Irlandia tetapi juga beroperasi di Prancis, telah dianugerahi hampir \u20ac 1,7 juta (sekitar US $ 1,99 juta) dalam dana non-dilutif melalui I-NOV, kompetisi inovasi dan program pemerintah Prancis (1) yang merupakan bagian dari inisiatif Prancis 2030, yang dioperasikan oleh BPIFRECRECRECRECE.<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Tambahan terapi sel CAR-T<\/strong><\/h2>\n<p class=\"pb-2\">Pendanaan ini akan mendukung program klinis yang berputar di sekitar Mocravimod Priothera, modulator reseptor sphingosine 1 fosfat (S1P) oral baru yang dikembangkan perusahaan untuk pengobatan keganasan hematologis (1). Lebih khusus lagi, program ini akan mengevaluasi apakah menambahkan mocravimod ke terapi sel antigen chimeric commercial (CAR) -T dapat meningkatkan hasil pasien.<\/p>\n<p class=\"pb-2\">Dalam siaran pers, Priothera mencatat potensi terapi sel CAR-T untuk memiliki respons klinis yang kuat dan kontrol penyakit yang langgeng pada pasien dengan leukemia limfoblastik akut, limfoma non-Hodgkin, dan multiple myeloma (1). Namun, perusahaan melanjutkan dengan mengatakan bahwa sebanyak 60% pasien yang diobati dengan sel CAR-T mengalami \u201ctoksisitas tingkat tinggi,\u201d seperti sindrom pelepasan sitokin (CRS) dan sindrom neurotoksisitas terkait sel efektor imun (ICANS). Mocravimod dirancang untuk meningkatkan efektivitas terapi sel CAR-T, menurut Priothera, dengan mekanisme aksi ganda yang mengurangi kejadian dan keparahan CRS dan ICAN, serta meningkatkan tingkat respons dan daya tahan pengobatan.<\/p>\n<p class=\"pb-2\">Priothera terus memajukan mocravimod dalam uji coba fase III global (MO-Trans) yang mempelajari kemanjuran pengobatan pada pasien dengan leukemia myeloid akut yang sedang menjalani transplantasi sel hematopoietik alogenik (Allo-HCT) (1).<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Pentingnya pendanaan lebih lanjut, penelitian<\/strong><\/h2>\n<p class=\"pb-2\">&#8220;Kami merasa terhormat untuk menerima dana I-NOV ini dari BPIFRANCE, yang menggarisbawahi inovasi dan potensi terapeutik Mocravimod di luar Allo-HCT,&#8221; kata Florent Gros, co-founder dan CEO Priothera, dalam siaran pers (1). \u201cDengan sifat imunomodulator yang unik, Mocravimod diposisikan dengan baik untuk menjadi komponen kunci dalam generasi berikutnya dari rejimen terapi sel. Percobaan MOCART mewakili perluasan yang menarik dari pengembangan klinis kami ke dalam terapi CAR-T, membangun keahlian mendalam kami dalam Allo-HCT dan momentum dari uji coba fase global III yang sedang berlangsung dalam fase global kami yang sedang berlangsung dalam fase global kami yang sedang berlangsung dalam fase global yang sedang berlangsung dalam fase global yang sedang berlangsung dalam fase global yang sedang berlangsung dalam fase global yang sedang berlangsung dalam fase global yang sedang berlangsung di mo-tr-trans myel dalam myel myel yang sedang berlangsung.<\/p>\n<p class=\"pb-2\">Atas nama pemerintah Prancis, Bpifrance mengelola dana benih teknologi Prancis, yang diidentifikasi sebagai salah satu co-leader putaran pembiayaan, juga sebagai bagian dari inisiatif Prancis 2030, untuk usaha biotek Franco-Belgia baru, Elkedonia (2). Perusahaan itu mengatakan pada Juni 2025 bahwa perusahaan itu mengumpulkan \u20ac 11,25 juta (US $ 12,9 juta) dalam putaran benih yang kelebihan permintaan untuk memajukan pendekatan terapi baru yang menargetkan depresi yang resistan terhadap pengobatan.<\/p>\n<p class=\"pb-2\">Sementara itu di Spanyol, manufaktur CAR-T akademik in-house telah muncul sebagai model alternatif baru, dimungkinkan oleh fleksibilitas peraturan yang memungkinkan produksi di ruang bersih kelas C daripada fasilitas kelas B yang lebih mahal (3). <em>Teknologi Farmasi<\/em>Seri &#8220;Behind The Headlines&#8221; \u00ae mengeksplorasi itu dan tren terkini lainnya dalam angsuran 19 Juni 2025.<\/p>\n<p class=\"pb-2\">Klik di sini untuk menonton diskusi panel itu secara keseluruhan.<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Referensi<\/strong><\/h2>\n<p class=\"pb-2\">1. Priothera. Priothera mengamankan \u20ac 1,7 juta pendanaan I-NOV oleh BPIFRANCE untuk program klinis kanker darah langka. Siaran pers. 24 Juni 2025.<br \/>2. Elkedonia. Elkedonia menutup putaran benih EUR 11 juta untuk memajukan neuroplastogen sebagai terapi baru untuk depresi dan gangguan neuropsikiatri. Siaran pers. 11 Juni 2025.<br \/>3. Spivey, C. Di belakang berita utama, Episode 19: Tekanan Biaya CGT, Langkah Curevac Biontech, dan Model Car-T Spanyol. <em>Pharmtech.com<\/em>19 Juni 2025.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rendering 3D CAR &#8211; Reseptor antigen chimeric antara sel -T dan sel kanker | Kredit Gambar: \u00a9 Alpha Tauri 3D &#8211; Stock.adobe.com Priothera, sebuah perusahaan biofarmasi tahap akhir yang berkantor pusat di Irlandia tetapi juga beroperasi di Prancis, telah dianugerahi hampir \u20ac 1,7 juta (sekitar US $ 1,99 juta) dalam dana non-dilutif melalui I-NOV, kompetisi [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":161,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis - Nova Anggreni, S.Farm, APT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis - Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"og:description\" content=\"Rendering 3D CAR &#8211; Reseptor antigen chimeric antara sel -T dan sel kanker | Kredit Gambar: \u00a9 Alpha Tauri 3D &#8211; Stock.adobe.com Priothera, sebuah perusahaan biofarmasi tahap akhir yang berkantor pusat di Irlandia tetapi juga beroperasi di Prancis, telah dianugerahi hampir \u20ac 1,7 juta (sekitar US $ 1,99 juta) dalam dana non-dilutif melalui I-NOV, kompetisi [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\" \/>\n<meta property=\"og:site_name\" content=\"Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-29T03:29:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500.jpg?fit=crop&amp;auto=format\" \/>\n<meta name=\"author\" content=\"pythonsonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"pythonsonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\"},\"author\":{\"name\":\"pythonsonline\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\"},\"headline\":\"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis\",\"datePublished\":\"2025-06-29T03:29:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\"},\"wordCount\":564,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\",\"url\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\",\"name\":\"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis - Nova Anggreni, S.Farm, APT\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg\",\"datePublished\":\"2025-06-29T03:29:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Beranda\",\"item\":\"https:\/\/pythonsonline.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pythonsonline.com\/#website\",\"url\":\"https:\/\/pythonsonline.com\/\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"description\":\"Keahlian Farmasi Bertemu Kekuatan Python\",\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pythonsonline.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pythonsonline.com\/#organization\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"url\":\"https:\/\/pythonsonline.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"width\":1080,\"height\":416,\"caption\":\"Nova Anggreni, S.Farm, APT\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\",\"name\":\"pythonsonline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"caption\":\"pythonsonline\"},\"sameAs\":[\"https:\/\/pythonsonline.com\"],\"url\":\"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis - Nova Anggreni, S.Farm, APT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/","og_locale":"id_ID","og_type":"article","og_title":"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis - Nova Anggreni, S.Farm, APT","og_description":"Rendering 3D CAR &#8211; Reseptor antigen chimeric antara sel -T dan sel kanker | Kredit Gambar: \u00a9 Alpha Tauri 3D &#8211; Stock.adobe.com Priothera, sebuah perusahaan biofarmasi tahap akhir yang berkantor pusat di Irlandia tetapi juga beroperasi di Prancis, telah dianugerahi hampir \u20ac 1,7 juta (sekitar US $ 1,99 juta) dalam dana non-dilutif melalui I-NOV, kompetisi [&hellip;]","og_url":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/","og_site_name":"Nova Anggreni, S.Farm, APT","article_published_time":"2025-06-29T03:29:20+00:00","og_image":[{"url":"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500.jpg?fit=crop&amp;auto=format","type":"","width":"","height":""}],"author":"pythonsonline","twitter_card":"summary_large_image","twitter_misc":{"Ditulis oleh":"pythonsonline","Estimasi waktu membaca":"3 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#article","isPartOf":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/"},"author":{"name":"pythonsonline","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156"},"headline":"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis","datePublished":"2025-06-29T03:29:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/"},"wordCount":564,"commentCount":0,"publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg","articleSection":["Blog"],"inLanguage":"id","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/","url":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/","name":"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis - Nova Anggreni, S.Farm, APT","isPartOf":{"@id":"https:\/\/pythonsonline.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg","datePublished":"2025-06-29T03:29:20+00:00","breadcrumb":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/"]}]},{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#primaryimage","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/06\/69b63304890253b8af0e4067835c50a055a0d124-2667x1500-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/06\/29\/priothera-dianugerahi-e-17-juta-dalam-kontes-inovasi-untuk-perawatan-keganasan-hematologis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Beranda","item":"https:\/\/pythonsonline.com\/"},{"@type":"ListItem","position":2,"name":"Priothera dianugerahi \u20ac 1,7 juta dalam kontes inovasi untuk perawatan keganasan hematologis"}]},{"@type":"WebSite","@id":"https:\/\/pythonsonline.com\/#website","url":"https:\/\/pythonsonline.com\/","name":"Nova Anggreni, S.Farm, APT","description":"Keahlian Farmasi Bertemu Kekuatan Python","publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pythonsonline.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/pythonsonline.com\/#organization","name":"Nova Anggreni, S.Farm, APT","url":"https:\/\/pythonsonline.com\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","width":1080,"height":416,"caption":"Nova Anggreni, S.Farm, APT"},"image":{"@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156","name":"pythonsonline","image":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","caption":"pythonsonline"},"sameAs":["https:\/\/pythonsonline.com"],"url":"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/"}]}},"_links":{"self":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/comments?post=160"}],"version-history":[{"count":0,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/160\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media\/161"}],"wp:attachment":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media?parent=160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/categories?post=160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/tags?post=160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}